NCT02940691View on ClinicalTrials.gov

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs

PHASE4TerminatedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

November 1, 2018

Study Completion Date

November 1, 2018

Conditions
Hepatitis C
Interventions
DRUG

Grazoprevir/elbasvir

Grazoprevir/elbasvir (100mg/50mg) once daily for 12 weeks.

Trial Locations (5)

2010

Kirketon Road Centre, Darlinghurst

St Vincent's Hospital, Darlinghurst

The Langton Centre, Darlinghurst

2300

Drug and Alcohol Clinical Services (Hunter), Newcastle

2751

Nepean Hospital, Kingswood

Sponsors

Lead Sponsor

Kirby Institute
All Listed Sponsors
lead

Kirby Institute

OTHER_GOV

NCT02940691 - Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs | Biotech Hunter | Biotech Hunter